360 related articles for article (PubMed ID: 9618465)
1. Cloning and characterization of human protease-activated receptor 4.
Xu WF; Andersen H; Whitmore TE; Presnell SR; Yee DP; Ching A; Gilbert T; Davie EW; Foster DC
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6642-6. PubMed ID: 9618465
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
[TBL] [Abstract][Full Text] [Related]
3. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
[TBL] [Abstract][Full Text] [Related]
4. Protease-activated receptor 1 (PAR1) and PAR4 heterodimers are required for PAR1-enhanced cleavage of PAR4 by α-thrombin.
Arachiche A; Mumaw MM; de la Fuente M; Nieman MT
J Biol Chem; 2013 Nov; 288(45):32553-32562. PubMed ID: 24097976
[TBL] [Abstract][Full Text] [Related]
5. Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2.
Miike S; McWilliam AS; Kita H
J Immunol; 2001 Dec; 167(11):6615-22. PubMed ID: 11714832
[TBL] [Abstract][Full Text] [Related]
6. Conserved structure and adjacent location of the thrombin receptor and protease-activated receptor 2 genes define a protease-activated receptor gene cluster.
Kahn M; Ishii K; Kuo WL; Piper M; Connolly A; Shi YP; Wu R; Lin CC; Coughlin SR
Mol Med; 1996 May; 2(3):349-57. PubMed ID: 8784787
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.
Ramachandran R; Sadofsky LR; Xiao Y; Botham A; Cowen M; Morice AH; Compton SJ
Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L788-98. PubMed ID: 17142351
[TBL] [Abstract][Full Text] [Related]
8. Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1.
O'Brien PJ; Prevost N; Molino M; Hollinger MK; Woolkalis MJ; Woulfe DS; Brass LF
J Biol Chem; 2000 May; 275(18):13502-9. PubMed ID: 10788464
[TBL] [Abstract][Full Text] [Related]
9. Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage.
Jacques SL; Kuliopulos A
Biochem J; 2003 Dec; 376(Pt 3):733-40. PubMed ID: 13678420
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil cathepsin G proteolysis of protease-activated receptor 4 generates a novel, functional tethered ligand.
Stoller ML; Basak I; Denorme F; Rowley JW; Alsobrooks J; Parsawar K; Nieman MT; Yost CC; Hamilton JR; Bray PF; Campbell RA
Blood Adv; 2022 Apr; 6(7):2303-2308. PubMed ID: 34883511
[TBL] [Abstract][Full Text] [Related]
11. Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells.
Colognato R; Slupsky JR; Jendrach M; Burysek L; Syrovets T; Simmet T
Blood; 2003 Oct; 102(7):2645-52. PubMed ID: 12805069
[TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries.
Hamilton JR; Moffatt JD; Frauman AG; Cocks TM
J Cardiovasc Pharmacol; 2001 Jul; 38(1):108-19. PubMed ID: 11444493
[TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
Hammes SR; Coughlin SR
Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
[TBL] [Abstract][Full Text] [Related]
14. Molecular mapping of thrombin-receptor interactions.
Ayala YM; Cantwell AM; Rose T; Bush LA; Arosio D; Di Cera E
Proteins; 2001 Nov; 45(2):107-16. PubMed ID: 11562940
[TBL] [Abstract][Full Text] [Related]
15. Protease-activated receptor 4 uses anionic residues to interact with alpha-thrombin in the absence or presence of protease-activated receptor 1.
Nieman MT
Biochemistry; 2008 Dec; 47(50):13279-86. PubMed ID: 19053259
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2.
Nystedt S; Emilsson K; Larsson AK; Strömbeck B; Sundelin J
Eur J Biochem; 1995 Aug; 232(1):84-9. PubMed ID: 7556175
[TBL] [Abstract][Full Text] [Related]
17. Novel mechanisms for activated protein C cytoprotective activities involving noncanonical activation of protease-activated receptor 3.
Burnier L; Mosnier LO
Blood; 2013 Aug; 122(5):807-16. PubMed ID: 23788139
[TBL] [Abstract][Full Text] [Related]
18. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR
J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109
[TBL] [Abstract][Full Text] [Related]
19. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1.
Kaufmann R; Schulze B; Krause G; Mayr LM; Settmacher U; Henklein P
Regul Pept; 2005 Feb; 125(1-3):61-6. PubMed ID: 15582715
[TBL] [Abstract][Full Text] [Related]
20. Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function.
Faruqi TR; Weiss EJ; Shapiro MJ; Huang W; Coughlin SR
J Biol Chem; 2000 Jun; 275(26):19728-34. PubMed ID: 10779527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]